Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study Authors
First Online: 01 June 2006 Received: 22 September 2005 Accepted: 01 February 2006 DOI:
Cite this article as: Romigi, A., Stanzione, P., Marciani, M. et al. J Neural Transm (2006) 113: 1909. doi:10.1007/s00702-006-0490-x Summary.
Few studies focused on the effects of cabergoline on sleep-wake cycle in PD. Twelve patients affected by PD treated with levodopa as monotherapy underwent two 24-hour ambulatory polysomnographic (A-PSG) sessions twice: in baseline condition (levodopa as monotherapy) and after addition of cabergoline. In each condition, a subjective evaluation of sleep quality and daytime sleepiness was obtained by means of Parkinson’s disease Sleep Scale (PDSS) and the Epworth Sleepiness Scale. The statistical analysis of sleep parameters revealed a significant increase of sleep efficiency and slow wave sleep under cabergoline. The PDSS total score showed a significant improvement of overall sleep quality after cabergoline. No significant changes in daytime sleepiness were observed. No patient referred and/or showed sleep attacks before and after addition of cabergoline. We hypothesize that the long-lasting effect of cabergoline may improve the objective quality of nocturnal sleep in PD patients complaining nocturnal motor disability without inducing daytime sleepiness.
Keywords: Parkinson’s disease, sleep, excessive daytime somnolence, cabergoline, polysomnography, Parkinson’s disease Sleep Scale, Epworth Sleepiness Scale References Arnulf, I, Konofal, E, Merino-Andreu, M, Houeto, JL, Mesnage, V, Welter, ML, Lacomblez, L, Golmard, JL, Derenne, JP, Agid, Y 2002 Parkinson’s disease and sleepiness: an integral part of PD Neurology 58 1019 1024 PubMed Askenasy, JJ 1993 Sleep in Parkinson’s disease Acta Neurologica Scan 87 167 170 CrossRef Baas, HKJ, Schueler, P 2001 Efficacy of cabergoline in long term use: results of three observational studies in 1500 patients with Parkinson’s disease Eur Neurol 46 18 23 PubMed CrossRef Carskadon, MA, Dement, WC 1992 Multiple sleep latency tests during the constant routine Sleep 15 396 399 PubMed Chaudhuri, KR, Pal, S, Bridgman, K, Trenkwalder, C 2001 Achieving 24-hour control of Parkinson’s disease symptoms: use of objective measures to improve nocturnal disability Eur Neurol 46 3 10 PubMed CrossRef Chaudhuri, KR, Pal, S, DiMarco, A, Whately-Smith, C, Bridgman, K, Mathew, R, Pezzela, FR, Forbes, A, Hogl, AB, Trenkwalder, C 2002a The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease J Neurol Neurosurg Psychiatry 73 629 635 CrossRef Chaudhuri, KR, Pal, S, Brefel-Courbon, C 2002b ‘Sleep attacks’ or ‘unintended sleep episodes’ occur whit dopamine agonists: is this a class effect? Drug Saf 25 473 483 CrossRef Chaudhuri, KR, Martinez-Martin, P 2004 Clinical assessment of nocturnal disability in Parkinson’s disease: the Parkinson’s disease Sleep Scale Neurology 63 S17 S20 PubMed Coleman, RM, Pollak, CP, Weitzman, ED 1980 Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorder Ann Neurol 8 416 421 PubMed CrossRef Del Dotto, P, Gambaccini, G, Caneparo, D, Berti, C, Bernardini, S, Bonuccelli, U 2003 Bedtime cabergoline in Parkinson’s disease patients with excessive daytime sleepiness induced by dopamine agonists Neurol Sci 24 170 171 PubMed CrossRef Factor, SA, McAlarney, T, Snachez-Ramos, JR, Weiner, WJ 1990 Sleep disorders and sleep effect in Parkinson’s disease Mov disord 5 280 285 PubMed CrossRef
Fahn S, Elton RL, Members of the UPDRS development committee (1997) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent development in Parkinson’s disease, Vol. 2 MacMillan Healthcare Information: Florham Park, NY, pp 153–163, 293–304
Fariello, RG 1998 Pharmacodynamic and pharmacokinetic features of cabergoline. Rationale for use in Parkinson’s disease Drugs 55 10 16 PubMed CrossRef Ferreira, JJ, Galitzky, M, Montastruc, JL, Rascol, O 2000 Sleep attacks and Parkinson’s disease treatment Lancet 355 1333 1334 PubMed CrossRef Frucht, S, Rogers, JD, Greene, PE, Gordon, MF, Fahn, S 1999 Falling asleep at the wheel: motor vehicle mishaps in person taking pramipexole and ropirinole Neurology 52 1908 1910 PubMed Garcia-Borreguero, D, Schwarz, C, Larrosa, O, de la Llave, Y, Garcia de Yebenes, J 2003 L-DOPA-induced excessive daytime somnolence in PD: a placebo-controlled case with MSLT assessment Neurology 61 1008 1010 PubMed Gigli, GL, Placidi, F, Diomedi, M, Maschio, M, Silvestri, G, Scalise, A, Marciani, MG 1996 Sleep in healthy elderly subjects: a 24-hour polysomnographic study Int J Neurosci 85 263 271 PubMed Goetz, CG, Blasucci, L, Stebbins, GT 1999 Switching dopamine agonists in advanced Parkinson’s disease: is rapid titration preferable to slow? Neurology 52 1227 1229 PubMed Grosset, K, Needleman, F, Macphee, G, Grosset, D 2004 Switching from ergot to nonergot dopamine agonists in Parkinson’s disease: a clinical series and five-drug dose conversion table Mov Disord Nov 19 370 374 Hogl, B, Rothdach, A, Wetter, TC, Trenkwalder, C 2003 The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson’s diesease Neuropsychopharmacology 28 1866 1870 PubMed CrossRef Homann, CN, Wenzel, K, Suppan, K, Ivanic, G, Kriechbaum, N, Crevenna, R, Ott, E 2002 Sleep attacks in patient taking dopamine agonists: review BMJ 324 1483 1487 PubMed CrossRef Johns, MW 1991 A new method for measuring daytime sleepiness: the Epworth sleepiness scale Sleep 14 540 545 PubMed Lang, AE, Hobson, DE, Martin, W, Rivest, J 2001 Excessive daytime somnolence and sudden onset sleep in Parkinson’s disease: a survey from 18 Canadian movement disorders clinics Neurology 56 A212 A213 Lera, G, Vaamonde, J, Rodriguez, M, Obeso, JA 1993 Cabergoline in Parkinson’s disease: long term follow-up Neurology 43 2587 2590 PubMed Nausieda, PA, Weiner, WJ, Kaplan, LR, Weber, S, Klawans, HL 1982 Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis Clin Neuropharmacol 5 183 194 PubMed Olanow, CW, Schapira, AH, Roth, T 2000 Waking up to sleep episodes in Parkinson’s disease Mov Disord 15 212 215 PubMed CrossRef Ondo, WG, Dat Vuong, K, Khan, H, Atassi, F, Kwak, C, Jankovic, J 2001 Daytime sleepiness and other sleep disorders in Parkinson’s disease Neurology 57 1392 1396 PubMed Pal, S, Bhattacharya, KF, Agapito, C, Chaudhuri, KR 2001 A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole cabergoline and levodopa mono and combination therapy J Neural Transm 108 71 77 PubMed CrossRef Paus, S, Brecht, HM, Koster, J, Seeger, G, Klockgether, T, Wullner, U 2003 Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease Mov Disord 18 659 667 PubMed CrossRef Poewe, W, Hogl, B 2000 Parkinson’s disease and sleep Curr Opin Neurol 13 423 426 PubMed CrossRef
Rechtshafen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute
Romigi, A, Brusa, L, Marciani, MG, Pierantozzi, M, Placidi, F, Izzi, F, Sperli, F, Testa, F, Stanzione, P 2005 Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study J Neurol Sci 228 7 10 PubMed CrossRef Romigi, A, Marciani, MG, Placidi, F 2004 L-dopa-induced excessive daytime somnolence in PD. A placebo-controlled case with MSLT assessment Neurology 62 1454 PubMed Rye, DB, Jankovic, J 2002 Emerging views of dopamine in modulation sleep/wake state from unlike source: PD Neurology 58 341 346 PubMed Tan, EK, Lum, SY, Fook-Chong, SM, Teoh, ML, Yih, Y, Tan, L, Tan, A, Wong, MC 2002 Evaluation of somnolence in Parkinson’s disease: comparison with age- and sex-matched controls Neurology 58 465 468 PubMed Tandberg, E, Larsen, JP, Karlsen, K 1998 A community-based study of sleep disorders in patients with Parkinson’disease Mov Disord 13 895 899 PubMed CrossRef Ulivelli, M, Rossi, S, Lombardi, C, Bartalini, S, Rocchi, R, Giannini, F, Passero, S, Battistini, N, Lugaresi, E 2002 Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD Neurology 58 462 465 PubMed van Hilten, JJ, Weggeman, M, van der velde, EA, Kerkhof, GA, van Dijk, JG, Roos, RA 1993 Sleep, excessive daytime sleepiness and fatigue in Parkinson’s disease J Neural Transm 5 235 244 CrossRef Wetter, TC, Collado-Seidel, V, Pollmacher, T, Yassouridi, SA, Trenkwalder, C 2000 Sleep and periodic leg movement pattern in drug-free patient with Parkinson’s disease and multiple system atrophy Sleep 23 361 367 PubMed